Clinical Study

Ea3163- Phase II Randomized Trial Of Neo-Adjuvant Chemotherapy Followed By Surgery And Post-Operative Radiation Versus Surgery And Post-Operative Radiation For Organ Preservation On T3 And T4a Nasal And Paranasal Sinus Squamous Cell Carcinoma (Npnscc

Posted Date: Oct 1, 2019

  • Investigator: Vinita Takiar
  • Specialties: Cancer, Head and Neck Cancer, Oncology
  • Type of Study: Observational/Survey

The goal of this study is to evaluate the structure preservation rate and overall survival (OS) for patients with locally advanced resectable NPNSCC with or without neoadjuvant therapy followed by surgical resection and postoperative standard care.

Criteria:

To Be Eligible: >18 Years Of Age, State T3 Or T4a Paranasal Squamous Cell Carcinoma, No Other Current Metastases, Nonpregnant/Nonbreastfeeding

Keywords:

Paranasal Sinus, Head And Neck Cancer

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.